PO
PODD
Quarter ended Jun 30, 2024 · FY2024 Q2

Insulet (PODD) Revenue — Quarter Ended Jun 30, 2024

Revenue for the quarter rose relative to the immediate prior quarter and also posted an increase compared to the same period one year earlier. The company’s financial position strengthened, with a lower debt-to-capital ratio.

Key takeaway

Quarter ended Jun 30, 2024 · FY2024 Q2

Revenue for the quarter rose relative to the immediate prior quarter and also posted an increase compared to the same period one year earlier. The company’s financial position strengthened, with a lower debt-to-capital ratio.

Financial snapshot

Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.

Quarter revenue

$488.5M

Revenue reported for this quarter.

Quarter-over-quarter

+10.6%

Change from the immediately preceding quarter.

Year-over-year

+23.2%

Change from the comparable year-ago quarter.

Trailing four quarters

$1.9B

Sum of the latest four reported quarters.

Quarterly revenue trend

The latest four reported quarters with year-over-year comparisons.

Period endedRevenueYear-over-year change
Sep 30, 2023$432.7M+27.0%
Dec 31, 2023$509.8M+37.9%
Mar 31, 2024$441.7M+23.3%
Jun 30, 2024$488.5M+23.2%

Revenue performance

The reported revenue continued on an upward trajectory, reflecting sustained growth.

Quarterly comparison

Sequentially, revenue increased from the preceding quarter. On a year-over-year basis, revenue was higher than the same quarter a year ago.

What to watch

The improvement in the net debt-to-total capital ratio indicates ongoing deleveraging, which may be a focus for future quarters.

Insulet (PODD) Revenue — Quarter Ended Jun 30, 2024